Citadel Advisors - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 2 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$197,000
-19.9%
160,768
+35.5%
0.00%
Q1 2022$246,000
-17.4%
118,685
-41.8%
0.00%
Q4 2021$298,000
-53.1%
203,797
-15.0%
0.00%
Q3 2021$635,000
-49.8%
239,699
-25.0%
0.00%
Q2 2021$1,266,000
+3.4%
319,788
+24.6%
0.00%
Q1 2021$1,224,000
+51.1%
256,631
+123.9%
0.00%
Q4 2020$810,000
-66.2%
114,600
-49.7%
0.00%
Q3 2020$2,399,000
+30.6%
227,831
+9.6%
0.00%
-100.0%
Q2 2020$1,837,000
+709.3%
207,800
+234.9%
0.00%
Q1 2020$227,000
+467.5%
62,044
+485.3%
0.00%
Q3 2019$40,00010,6000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 37,191$139,0000.08%
ARK Investment Management 539,417$2,017,0000.04%
Nikko Asset Management Americas, Inc. 215,742$807,0000.01%
ETF MANAGERS GROUP, LLC 44,571$178,0000.01%
Verition Fund Management LLC 20,550$77,0000.00%
Renaissance Technologies 186,231$697,0000.00%
Certified Advisory Corp 500$2,0000.00%
Sumitomo Mitsui Trust Holdings, Inc. 215,742$807,0000.00%
MORGAN STANLEY 1,580$5,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 18,170$68,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders